CDK5RAP2	chr9	120,388,874	120,580,167	minus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the CDK5RAP2 gene on chr9 with a variant allele frequency (VAF) of [%].	NA
CDX2	chr13	27,960,917	27,969,315	minus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the CDX2 gene on chr13 with a variant allele frequency (VAF) of [%].	NA
CNTRL	chr9	121,074,954	121,177,610	plus	NA	NA	NA	NA	No	Yes	Yes	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the CNTRL gene on chr9 with a variant allele frequency (VAF) of [%].	NA
CRLF2_chrX	chrX	1,190,489	1,212,649	minus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the CRLF2_chrX gene on chrX with a variant allele frequency (VAF) of [%].	NA
CRLF2_chrY	chrY	1,190,489	1,212,649	minus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the CRLF2_chrY gene on chrY with a variant allele frequency (VAF) of [%].	NA
CTNNA1	chr5	138,753,424	138,935,034	plus	NA	NA	NA	NA	No	Yes	Yes	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the CTNNA1 gene on chr5 with a variant allele frequency (VAF) of [%].	NA
DDX41	chr5	177,511,577	177,516,961	minus	Subtypes of myeloid neoplasms associated with germline predisposition; Myeloid neoplasms with germline predisposition without a pre-existing platelet disorder or organ dysfunction, (WHO, PMID: 35732831).	Hematologic neoplasms with germline predisposition without a constitutional disorder affecting multiple organ systems; Myeloid or lymphoid neoplasms with germline DDX41 mutation, (ICC, PMID: 35767897).	NA	NA	Expanded	Yes	Yes	NA	NA	AML	1A	NA	Optical Genome Mapping detected a [  ] mutation involving the DDX41 gene on chr5 with a variant allele frequency (VAF) of [%].	NA
EED	chr11	86,244,383	86,278,813	NA	NA	NA	NA	NA	No	No	Yes	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the EED gene on chr11 with a variant allele frequency (VAF) of [%].	NA
EGR1	chr5	138,465,478	138,469,303	plus	NA	NA	NA	NA	No	Yes	Yes	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the EGR1 gene on chr5 with a variant allele frequency (VAF) of [%].	NA
EP300	chr22	41,092,591	41,180,077	plus	NA	NA	NA	NA	No	Yes	Yes	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the EP300 gene on chr22 with a variant allele frequency (VAF) of [%].	NA
ETNK1	chr12	22,625,170	22,690,665	plus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the ETNK1 gene on chr12 with a variant allele frequency (VAF) of [%].	NA
FEV	chr2	218,981,086	218,985,184	minus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the FEV gene on chr2 with a variant allele frequency (VAF) of [%].	NA
FIP1L1	chr4	53,377,640	53,460,862	plus	NA	NA	NA	NA	No	Yes	Yes	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the FIP1L1 gene on chr4 with a variant allele frequency (VAF) of [%].	NA
GATA1	chrX	48,786,589	48,794,311	plus	NA	NA	NA	NA	Expanded	Yes	Yes	NA	NA	AML	3A	NA	Optical Genome Mapping detected a [  ] mutation involving the GATA1 gene on chrX with a variant allele frequency (VAF) of [%].	NA
GIT2	chr12	109,929,803	109,996,368	minus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the GIT2 gene on chr12 with a variant allele frequency (VAF) of [%].	NA
GNAS	chr20	58,891,420	58,911,192	plus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the GNAS gene on chr20 with a variant allele frequency (VAF) of [%].	NA
GNB1	chr1	1,785,285	1,891,087	minus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the GNB1 gene on chr1 with a variant allele frequency (VAF) of [%].	NA
GOLGA4	chr3	37,243,270	37,366,879	plus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the GOLGA4 gene on chr3 with a variant allele frequency (VAF) of [%].	NA
GSKIP	chr14	96,363,525	96,387,288	plus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the GSKIP gene on chr14 with a variant allele frequency (VAF) of [%].	NA
HIP1	chr7	75,533,297	75,738,941	minus	NA	NA	NA	NA	No	Yes	Yes	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the HIP1 gene on chr7 with a variant allele frequency (VAF) of [%].	NA
IRF1	chr5	132,481,608	132,490,773	minus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the IRF1 gene on chr5 with a variant allele frequency (VAF) of [%].	NA
KANK1	chr9	504,694	746,103	plus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the KANK1 gene on chr9 with a variant allele frequency (VAF) of [%].	NA
KIF5B	chr10	32,009,014	32,056,425	minus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the KIF5B gene on chr10 with a variant allele frequency (VAF) of [%].	NA
MRTFA	chr22	40,410,281	40,636,719	minus	Acute myeloid leukaemia with defining genetic abnormalities; Acute myeloid leukaemia with RBM15::MRTFA fusion, (WHO, PMID: 35732831).	NA	NA	NA	No	Yes	No	NA	NA	AML	1A	NA	Optical Genome Mapping detected a [  ] mutation involving the MRTFA gene on chr22 with a variant allele frequency (VAF) of [%].	NA
MYB	chr6	135,181,307	135,219,172	plus	NA	NA	NA	NA	No	Yes	Yes	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the MYB gene on chr6 with a variant allele frequency (VAF) of [%].	NA
MYD88	chr3	38,138,660	38,143,022	plus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the MYD88 gene on chr3 with a variant allele frequency (VAF) of [%].	NA
MYSM1	chr1	58,654,744	58,700,062	minus	NA	NA	NA	NA	Expanded	No	No	NA	NA	AML	3A	NA	Optical Genome Mapping detected a [  ] mutation involving the MYSM1 gene on chr1 with a variant allele frequency (VAF) of [%].	NA
NFE2	chr12	54,292,110	54,295,758	minus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the NFE2 gene on chr12 with a variant allele frequency (VAF) of [%].	NA
NIN	chr14	50,719,762	50,831,162	minus	NA	NA	NA	NA	No	Yes	Yes	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the NIN gene on chr14 with a variant allele frequency (VAF) of [%].	NA
P2RY8_chrX	chrX	1,462,580	1,537,185	minus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the P2RY8_chrX gene on chrX with a variant allele frequency (VAF) of [%].	NA
P2RY8_chrY	chrY	1,462,580	1,537,185	minus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the P2RY8_chrY gene on chrY with a variant allele frequency (VAF) of [%].	NA
PCM1	chr8	17,922,987	18,029,948	plus	NA	NA	NA	NA	No	Yes	Yes	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the PCM1 gene on chr8 with a variant allele frequency (VAF) of [%].	NA
PDE4DIP	chr1	148,844,427	149,033,016	plus	NA	NA	NA	NA	No	Yes	Yes	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the PDE4DIP gene on chr1 with a variant allele frequency (VAF) of [%].	NA
PPM1D	chr17	60,600,192	60,666,280	plus	NA	NA	NA	NA	Expanded	Yes	Yes	NA	NA	AML	3A	NA	Optical Genome Mapping detected a [  ] mutation involving the PPM1D gene on chr17 with a variant allele frequency (VAF) of [%].	NA
PRKG2	chr4	81,087,374	81,215,222	minus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the PRKG2 gene on chr4 with a variant allele frequency (VAF) of [%].	NA
PRPF40B	chr12	49,623,414	49,644,669	plus	NA	NA	NA	NA	Core	No	Yes	NA	NA	AML	3A	NA	Optical Genome Mapping detected a [  ] mutation involving the PRPF40B gene on chr12 with a variant allele frequency (VAF) of [%].	NA
PRPF8	chr17	1,650,628	1,684,867	minus	NA	NA	NA	NA	No	Yes	Yes	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the PRPF8 gene on chr17 with a variant allele frequency (VAF) of [%].	NA
RABEP1	chr17	5,282,283	5,386,340	plus	NA	NA	NA	NA	No	Yes	Yes	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the RABEP1 gene on chr17 with a variant allele frequency (VAF) of [%].	NA
RIT1	chr1	155,897,808	155,911,349	minus	NA	NA	NA	NA	Expanded	No	No	NA	NA	AML	3A	NA	Optical Genome Mapping detected a [  ] mutation involving the RIT1 gene on chr1 with a variant allele frequency (VAF) of [%].	NA
RPL11	chr1	23,691,806	23,696,835	plus	NA	NA	NA	NA	Expanded	No	No	NA	NA	AML	3A	NA	Optical Genome Mapping detected a [  ] mutation involving the RPL11 gene on chr1 with a variant allele frequency (VAF) of [%].	NA
SAMD9	chr7	93,099,513	93,118,023	minus	NA	Hematologic neoplasms with germline predisposition associated with a constitutional disorder affecting multiple organ systems; Myeloid neoplasms with germline SAMD9 mutation, (ICC, PMID: 35767897).	NA	NA	Expanded	No	No	NA	NA	AML	1A	NA	Optical Genome Mapping detected a [  ] mutation involving the SAMD9 gene on chr7 with a variant allele frequency (VAF) of [%].	NA
SAMD9L	chr7	93,130,056	93,148,385	minus	NA	Hematologic neoplasms with germline predisposition associated with a constitutional disorder affecting multiple organ systems; Myeloid neoplasms with germline SAMD9L mutation, (ICC, PMID: 35767897).	NA	NA	No	No	No	NA	NA	AML	1A	NA	Optical Genome Mapping detected a [  ] mutation involving the SAMD9L gene on chr7 with a variant allele frequency (VAF) of [%].	NA
SBDS	chr7	66,987,680	66,995,586	minus	NA	NA	NA	NA	Expanded	No	Yes	NA	NA	AML	3A	NA	Optical Genome Mapping detected a [  ] mutation involving the SBDS gene on chr7 with a variant allele frequency (VAF) of [%].	NA
SETBP1	chr18	44,680,887	45,068,510	plus	NA	NA	NA	NA	Expanded	Yes	Yes	NA	NA	AML	3A	NA	Optical Genome Mapping detected a [  ] mutation involving the SETBP1 gene on chr18 with a variant allele frequency (VAF) of [%].	NA
SF1	chr11	64,764,604	64,778,844	minus	NA	NA	NA	NA	Core	No	Yes	NA	NA	AML	3A	NA	Optical Genome Mapping detected a [  ] mutation involving the SF1 gene on chr11 with a variant allele frequency (VAF) of [%].	NA
SF3A1	chr22	30,331,988	30,356,894	minus	NA	NA	NA	NA	Core	No	Yes	NA	NA	AML	3A	NA	Optical Genome Mapping detected a [  ] mutation involving the SF3A1 gene on chr22 with a variant allele frequency (VAF) of [%].	NA
SF3B1	chr2	197,388,515	197,435,079	minus	Classification and defining features of myelodysplastic neoplasms (MDS); MDS with low blasts and SF3B1 mutationa (MDS-SF3B1). Defining somatic mutations in acute myeloid leukaemia, myelodysplasia-related; Cytogenetic and molecular abnormalities defining acute myeloid leukaemia, myelodysplasia-related., (WHO, PMID: 35732831).	Classification of AML with percentage of blasts required for diagnosis; Defined by mutations in ASXL1, BCOR, EZH2, RUNX1, SF3B1, SRSF2, STAG2, U2AF1, or ZRSR2. Premalignant clonal cytopenias and myelodysplastic syndromes; Myelodysplastic syndrome with mutated SF3B1, (ICC, PMID: 35767897).	NA	NA	Core	Yes	Yes	NA	NA	AML	1A	NA	Optical Genome Mapping detected a [  ] mutation involving the SF3B1 gene on chr2 with a variant allele frequency (VAF) of [%].	NA
SOCS3	chr17	78,356,777	78,360,079	minus	NA	NA	NA	NA	Core	No	Yes	NA	NA	AML	3A	NA	Optical Genome Mapping detected a [  ] mutation involving the SOCS3 gene on chr17 with a variant allele frequency (VAF) of [%].	NA
SPTBN1	chr2	54,456,326	54,671,446	plus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the SPTBN1 gene on chr2 with a variant allele frequency (VAF) of [%].	NA
SRP72	chr4	56,467,617	56,503,681	plus	NA	NA	NA	NA	Expanded	No	No	NA	NA	AML	3A	NA	Optical Genome Mapping detected a [  ] mutation involving the SRP72 gene on chr4 with a variant allele frequency (VAF) of [%].	NA
STAT3	chr17	42,313,323	42,388,442	minus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the STAT3 gene on chr17 with a variant allele frequency (VAF) of [%].	NA
STAT5a	chr17	42,287,546	42,311,943	plus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the STAT5a gene on chr17 with a variant allele frequency (VAF) of [%].	NA
STAT5b	chr17	42,199,176	42,276,391	minus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the STAT5b gene on chr17 with a variant allele frequency (VAF) of [%].	NA
STIM1	chr11	3,855,664	4,093,208	plus	NA	NA	NA	NA	Expanded	No	No	NA	NA	AML	3A	NA	Optical Genome Mapping detected a [  ] mutation involving the STIM1 gene on chr11 with a variant allele frequency (VAF) of [%].	NA
STRN	chr2	36,837,697	36,966,536	minus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the STRN gene on chr2 with a variant allele frequency (VAF) of [%].	NA
SUZ12	chr17	31,937,009	32,001,045	NA	NA	NA	NA	NA	No	No	Yes	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the SUZ12 gene on chr17 with a variant allele frequency (VAF) of [%].	NA
TP53BP1	chr15	43,403,060	43,493,156	minus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the TP53BP1 gene on chr15 with a variant allele frequency (VAF) of [%].	NA
UBA1	chrX	47,193,828	47,215,128	plus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the UBA1 gene on chrX with a variant allele frequency (VAF) of [%].	NA
USP2	chr11	119,355,214	119,381,690	minus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the USP2 gene on chr11 with a variant allele frequency (VAF) of [%].	NA
WDR48	chr3	39,052,015	39,096,664	plus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the WDR48 gene on chr3 with a variant allele frequency (VAF) of [%].	NA
ZMYM2	chr13	19,958,726	20,089,115	plus	NA	NA	NA	NA	No	Yes	Yes	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the ZMYM2 gene on chr13 with a variant allele frequency (VAF) of [%].	NA
ZNF292	chr6	87,155,564	87,265,943	plus	NA	NA	NA	NA	No	Yes	No	NA	NA	AML	2	NA	Optical Genome Mapping detected a [  ] mutation involving the ZNF292 gene on chr6 with a variant allele frequency (VAF) of [%].	NA
